Coldstream Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
2,870
-1,288
-31% -$113K ﹤0.01% 1058
2026
Q1
$376K Buy
4,158
+1,627
+64% +$149K ﹤0.01% 844
2025
Q4
$228K Sell
2,531
-187
-7% -$17.7K ﹤0.01% 1036
2025
Q3
$268K Buy
+2,718
New +$269K ﹤0.01% 991
2025
Q2
Sell
-2,885
Closed -$327K 3420
2025
Q1
$327K Buy
2,885
+78
+3% +$8.34K 0.01% 777
2024
Q4
$297K Buy
2,807
+24
+0.9% +$2.58K 0.01% 832
2024
Q3
$301K Sell
2,783
-19
-0.7% -$2.07K 0.01% 841
2024
Q2
$304K Sell
2,802
-380
-12% -$44.8K 0.01% 750
2024
Q1
$420K Buy
3,182
+340
+12% +$42.5K 0.01% 626
2023
Q4
$346K Buy
2,842
+170
+6% +$19K 0.01% 651
2023
Q3
$300K Buy
2,672
+303
+13% +$38.5K 0.01% 598
2023
Q2
$345K Buy
2,369
+13
+0.6% +$1.77K 0.01% 576
2023
Q1
$304K Buy
2,356
+25
+1% +$3.14K 0.01% 623
2022
Q4
$297K Buy
+2,331
New +$271K 0.01% 600
2022
Q2
Sell
-1,945
Closed -$249K 857
2022
Q1
$249K Sell
1,945
-123
-6% -$14.8K 0.01% 654
2021
Q4
$255K Buy
+2,068
New +$271K 0.01% 689

Other funds holding ZBH

Coldstream Capital Management's ZBH Position: Q2 2026 in Review

Coldstream Capital Management reduced its Zimmer Biomet (ZBH) stake by 31% in Q2 2026, selling an estimated $113K and leaving 2,870 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Coldstream Capital Management first reported a position in ZBH in Q4 2021 and has held it in 16 quarters since. The position peaked at $420K in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Coldstream Capital Management held 2,870 shares of Zimmer Biomet worth $247K as of Q2 2026.
  • Coldstream Capital Management sold 1,288 Zimmer Biomet shares in Q2 2026, an estimated $113K.
  • Zimmer Biomet made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1058 holding.
  • Coldstream Capital Management first reported a position in Zimmer Biomet in Q4 2021 and has held it in 16 quarters since.
  • Coldstream Capital Management's Zimmer Biomet position peaked at $420K in Q1 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.